Thursday, March 12, 2015 7:16:02 PM
Mr James Nathanielsz Chief Executive Officer
Director & C.E.O, Oct ‘07.
15 yrs. experience in R&D, Manufacturing & Distribution, including 10 yrs. in oncology
Bachelor of Applied Science (Biochemistry/Applied Chemistry) & Master of Entrepreneurship & Innovation, Swinburne University, Melbourne, Australia.
Dr Julian Kenyon Chief Scientific Officer
Co-Founder & Director, Feb ‘08.
Medical Director of the Dove Clinic for Integrated Medicine, UK, since 2000.
Bachelor of Medicine & Surgery & Doctor of Medicine , University of Liverpool.
Primary Fellow of the Royal College of Surgeons, Edinburgh for over 40 years.
Prof. Klaus Kutz Chief Medical Officer
15 yrs. experience as consultant in Clinical Pharmacology & Safety in oncology.
12 yrs. experience Head of Clinical Pharmacology in 2 multinational pharma companies.
Specialist for Internal Medicine, Gastroenterology & Clinical Pharmacology.
Professor of Medicine, University of Bonn, Germany.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM